Less understood is the contribution of methylenetetrahydrofolate reductase (MTHFR) mutations, which impair homocysteine metabolism, leading to hyperhomocysteinemia and associated endothelial dysfunction, oxidative stress, and platelet activation [7]. The gene discussed is MTHFR; the disease is endothelial dysfunction.